摘要
目的:了解血液透析患者骨代谢和骨病控制情况。方法:对我院血液净化中心血液透析的92例患者骨代谢指标进行调查,并与国际肾脏病基金会慢性透析患者骨代谢和骨病控制指南进行比较。结果:92例中,有84例(91.05%)血清钙浓度、42例(45.36%)磷浓度、60例(67.2%)钙磷乘积、65例(59.79%)PTH达到K/DOQI所要求的目标,但仅有20例(占21.7%)患者所有指标均达到要求目标。结论:多数血液透析患者骨代谢和骨病控制仍然不能达到K/DOQI要求的目标。
Objective：To understand the bone metablism and the controling situation of the bony disease. Methods： Laboratory parameters of bone and mineral metabolism were investigated in 92 patients in hemodialysis centre of our hospital and compared with the bone metabolism and guideine of bony disease in chronic hemodialysis patient. Results： The levels of serum calcium and serum phosphorus fell within the range reccmmended by the K/DOQI guidelines 91.05%and45.36%of the time respectively. 67.2%of the determinations for calcium＇ phosphorus product was〈55m^2/dl^2. PTH levels were within the recommended values in 59.79%ofthedeterminations. Only 21.7%of the determinations met all four criteria. Conclusion： The bone metablism and the control of the bony disease in most hemodialytie patients still cannot reach the K/DOQI guidelines.
出处
《温州医学院学报》
CAS
2006年第6期536-538,共3页
Journal of Wenzhou Medical College
关键词
肾透析
甲状旁腺功能亢进症
继发
钙代谢障碍
磷代谢障碍
kidney, hyperparathyroidism, secondary, calcium metabolism disorder, phosphorus metabolism disorder
